GlassScriptPhysician profile
Alexander C Hennig
NPI 1104958073
$4,719.62
in general payments reported to CMS, 2019-2025
13 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,554 · 2020: $67.83 · 2021: $156 · 2024: $163 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.56 |
| Travel and Lodging | $324.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $3,217.41 | 2019 | |
| Miach Orthopaedics, INC. | $656.22 | 2025 | |
| Stryker Corporation | $158.70 | 2019-2024 | Gamma |
| Pacira Therapeutics, INC. | $148.18 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $126.78 | 2019-2024 | Euflexxa |
| Innovation Technologies INC | $101.70 | 2024 | Irrisept |
| Endo Pharmaceuticals INC. | $93.90 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $90.61 | 2019-2025 | Iovera, Exparel, Zilretta |
| Kairos Surgical INC | $36.41 | 2025 | |
| Orthofix Medical, INC. | $33.83 | 2025 | Spinal-Stim |
| Vertex Pharmaceuticals Incorporated | $26.07 | 2025 | |
| Bioventus LLC | $18.06 | 2019 | |
| Smith+Nephew, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Hennig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.